Pfaar, Oliver <br/><br/>
Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  03 2019 
 - 970-977 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6825 
<br/><br/><label>Standard No.: </label>10.1016/j.jaci.2018.11.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Allergens--immunology<br/>Antigens, Plant--immunology<br/>Asthma--therapy<br/>Betula--immunology<br/>Conjunctivitis, Allergic--therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pollen--immunology<br/>Rhinitis, Allergic, Seasonal--therapy<br/>Sublingual Immunotherapy--adverse effects<br/>Treatment Outcome<br/>Young Adult